Invitation
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Orexo and GoGoMeds Partner to Bring Digital Therapies to Populations Battling Addiction and Depression with Limited Support Options
Alcohol and opioid misuse, and depression on the rise because of COVID-19 prompts response to address urgent needPressrelease
Orexo and Lyfebulb Announce the Finalists and Jury for the 2020 Innovation Challenge in Substance Use Disorders
The Challenge recognizes Patient Entrepreneurs with solutions that aid successful, long-term recovery from alcohol and opioid use disordersPressrelease
Pressrelease
Pressrelease
Pressrelease
Orexo and Lyfebulb Announce Call for Digital Solutions to Treat Substance Use Disorder
Winning Entry to Receive USD 25,000 GrantNews
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Invitation
Invitation
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease
Pressrelease